Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports

🤖 AI Analyzed

Recent

📄 Page 339 of 434

Intellia Therapeutics, Inc.

10-K February 26, 2026

Key Highlights

Positive clinical data for NTLA-2001 (ATTR amyloidosis) advancing to pivotal Pha...
Promising Phase 1/2 data for NTLA-2002 (HAE) suggesting single-dose treatment po...
Strong financial position with $1.2 billion in cash, providing an estimated 2.5-...

Read Analysis

🤖 AI Generated

Ingevity Corp

10-K February 26, 2026

Key Highlights

Improved profitability in 2025 despite a 5.2% revenue decline, driven by increas...
Strong cash flow generation with $300 million from operations and $150 million i...
Stable financial health with a healthy 1.5x Net Debt to Adjusted EBITDA ratio an...

Read Analysis

🤖 AI Generated

TORM plc

20-F February 26, 2026

Key Highlights

TORM plc operates a dominant "Tanker" segment for refined oil products and a spe...
A consistent leadership team with Long Term Incentive Plans ensures alignment be...
The company maintains a diversified financing approach, utilizing Senior Unsecur...

Read Analysis

🤖 AI Generated

Cronos Group Inc.

10-K February 26, 2026

Key Highlights

Strong cash and short-term investments balance of approximately $800 million pro...
Strategic transformation underway, focusing on streamlining operations and core ...
Significant R&D partnership with Ginkgo Bioworks Inc. for developing new, rare c...

Read Analysis

🤖 AI Generated

Kimbell Royalty Partners, LP

10-K February 26, 2026

Key Highlights

Operates as a royalty company in the oil and natural gas industry, benefiting fr...
Represented a market value of approximately $1.2 billion as of early 2024.
Maintained strong distributions to unitholders, declaring $1.50 per common unit ...

Read Analysis

🤖 AI Generated

HERTZ GLOBAL HOLDINGS, INC

10-K February 26, 2026

Key Highlights

Strong revenue growth in 2025, up 5% to $9.8 billion, primarily driven by the Am...
Significant rebound in net income to $150 million in 2025, recovering from a $50...
Successful strategic EV fleet divestment in 2024, expected to enhance long-term ...

Read Analysis

🤖 AI Generated

Crinetics Pharmaceuticals, Inc.

10-K February 26, 2026

Key Highlights

Successful completion of Phase 3 trial for lead drug candidate, Paltopato, for A...
Strong cash position of $450 million (as of Dec 31, 2025), projected to fund ope...
Strategic licensing agreement with Sanwa Kagaku Kenkyusho Co. Ltd. for Paltopato...

Read Analysis

🤖 AI Generated

Permian Resources Corp

10-K February 26, 2026

Key Highlights

Strategic focus on the highly prolific Permian Basin, including the Midland and ...
Significant growth in 2023 through the Earthstone merger, expanding operational ...
Strong competitive advantages from a high-quality asset base, operational effici...

Read Analysis

🤖 AI Generated

Organogenesis Holdings Inc.

10-K February 26, 2026

Key Highlights

Solid 8% revenue growth in 2025, reaching $450 million.
Successful launch of 'ReGenDerm' exceeding initial sales expectations.
Positive Phase 2 clinical trial results for 'BioMatrix', advancing to Phase 3.

Read Analysis

🤖 AI Generated

C4 Therapeutics, Inc.

10-K February 26, 2026

Key Highlights

Pioneering targeted protein degradation (TPD) with proprietary TORPEDO™ platform...
Strategic collaborations with major pharmaceutical companies (Merck KGaA, Roche,...
Advancing a robust internal pipeline and maintaining a debt-free balance sheet a...

Read Analysis

🤖 AI Generated

Sezzle Inc.

10-K February 26, 2026

Key Highlights

Achieved positive Adjusted EBITDA of $5 million for fiscal year 2023, signaling ...
Reported strong revenue growth of 22% to $145 million and a 15% increase in Gros...
Grew active consumer base by 10% to 3.5 million and expanded active merchant net...

Read Analysis

🤖 AI Generated

Hilton Grand Vacations Inc.

10-K February 26, 2026

Key Highlights

Achieved solid revenue growth of 5.6% to $4.18 billion and an 8.5% increase in n...
Generated robust operating cash flow of $620 million and free cash flow of $450 ...
Improved net income margin to 9.1% and demonstrated effective cost control, incl...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage